Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT chemotherapy with or without surgery in limited metastatic gastric cancer
NCT02578368Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Feb 2016
- Primary completion
- Aug 2024
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil, folinic acid, oxaliplatin, docetaxel in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Krankenhaus Nordwest. Started Feb 2016; status: completed.
02
Drugs
fluorouracilfolinic acidoxaliplatindocetaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT02578368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578368.